Tone mix
Week by week 52 weeks
Share of Axsome Therapeutics, Inc's 188 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 3, 2026 · tone -100Axsome Therapeutics (NASDAQ:AXSM) Stock Price Down 4% After Analyst Downgrade-139
- Week of Jun 22, 2026 · tone +97Axsome Therapeutics (NASDAQ:AXSM) Hits New 1-Year High on Analyst Upgrade+76
- Week of Sep 15, 2025 · tone +100Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring A Potential 49% Upside In The Biotech Sector+72
- Week of May 11, 2026 · tone +98Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer's Agitation Launch+61
- Week of Jul 20, 2026 · tone +100Axsome Therapeutics' (AXSM) "Buy" Rating Reiterated at HC Wainwright+60
- Week of Oct 6, 2025 · tone +95How Herriot Tabuteau Turned BioTech Risk Into A $6B Empire+59
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Axsome Therapeutics, Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 15 | -20 |
| Last 30 sessions | 26 | -8 |
| Last 90 sessions | 61 | +11 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
3 headlines, average tone -67: 0 positive, 1 neutral and 2 negative. Showing all 3.
- www.fool.com · 2 outletsAxsome Therapeutics vs. BioNTech: Which Healthcare Stock Is a Better Buy for 2027?Neutral
- www.tickerreport.com · 1 outletAxsome Therapeutics (NASDAQ:AXSM) Stock Gets Price Target Reduction from Robert W. BairdNegative
- www.themarketsdaily.com · 1 outletAxsome Therapeutics (NASDAQ:AXSM) Stock Gets Price Target Reduction from Royal Bank Of CanadaNegative
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Axsome Therapeutics vs. BioNTech: Which Healthcare Stock Is a Better Buy for 2027? | www.fool.com | 2 | Neutral |
| Axsome Therapeutics (NASDAQ:AXSM) Stock Gets Price Target Reduction from Robert W. Baird | www.tickerreport.com | 1 | Negative |
| Axsome Therapeutics (NASDAQ:AXSM) Stock Gets Price Target Reduction from Royal Bank Of Canada | www.themarketsdaily.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
3 headlines, average tone -100: 0 positive, 0 neutral and 3 negative. Showing all 3.
- www.dailypolitical.com · 1 outletAxsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $250.00 by Analysts at GuggenheimNegative
- www.tickerreport.com · 1 outletAxsome Therapeutics (NASDAQ:AXSM) Stock Price Target Cut by Royal Bank Of CanadaNegative
- www.dailypolitical.com · 1 outletAxsome Therapeutics (NASDAQ:AXSM) Stock Price Target Lowered at Royal Bank Of CanadaNegative
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Axsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $250.00 by Analysts at Guggenheim | www.dailypolitical.com | 1 | Negative |
| Axsome Therapeutics (NASDAQ:AXSM) Stock Price Target Cut by Royal Bank Of Canada | www.tickerreport.com | 1 | Negative |
| Axsome Therapeutics (NASDAQ:AXSM) Stock Price Target Lowered at Royal Bank Of Canada | www.dailypolitical.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
5 headlines, average tone 0: 1 positive, 3 neutral and 1 negative. Showing all 5.
- www.themarketsdaily.com · 1 outletAxsome Therapeutics (NASDAQ:AXSM) Stock Gets Price Target Reduction from Robert W. BairdNegative
- www.rttnews.com · 1 outletAxsome Therapeutics Q3 Sales Rise Across Key Brands; Pipeline Milestones Set For 2027Positive
- www.manilatimes.net · 1 outletAxsome Therapeutics to Participate in Upcoming Investor ConferencesNeutral
- www.themarketsdaily.com · 1 outletWhat Axsome Therapeutics (AXSM) Said on Its Q3 Earnings CallNeutral
- www.fool.com · 1 outletAxsome (AXSM) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Axsome Therapeutics (NASDAQ:AXSM) Stock Gets Price Target Reduction from Robert W. Baird | www.themarketsdaily.com | 1 | Negative |
| Axsome Therapeutics Q3 Sales Rise Across Key Brands; Pipeline Milestones Set For 2027 | www.rttnews.com | 1 | Positive |
| Axsome Therapeutics to Participate in Upcoming Investor Conferences | www.manilatimes.net | 1 | Neutral |
| What Axsome Therapeutics (AXSM) Said on Its Q3 Earnings Call | www.themarketsdaily.com | 1 | Neutral |
| Axsome (AXSM) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletAxsome Therapeutics (NASDAQ:AXSM) Posts Earnings Results, Beats Expectations By $0.38 EPSPositive
- www.manilatimes.net · 1 outletAxsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business UpdateNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Axsome Therapeutics (NASDAQ:AXSM) Posts Earnings Results, Beats Expectations By $0.38 EPS | www.themarketsdaily.com | 1 | Positive |
| Axsome Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 30, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.aol.com · 1 outletCould Axsome Therapeutics Turn $5,000 Into $50,000 by 2035?Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Could Axsome Therapeutics Turn $5,000 Into $50,000 by 2035? | www.aol.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Axsome Therapeutics, Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.